8 related articles for article (PubMed ID: 38733648)
1. ETV6-NTRK2 Fusion in a Patient With Metastatic Pulmonary Atypical Carcinoid Successfully Treated With Entrectinib: A Case Report and Review of the Literature.
Zhang W; Tian S; Li X; Chen Y; Wang X; Zhang Y; Lv L; Li Y; Shi H; Bai C
Clin Lung Cancer; 2024 May; 25(3):215-224.e3. PubMed ID: 38584068
[TBL] [Abstract][Full Text] [Related]
2. Beyond Clinical Trials: Understanding Neurotrophic Tropomyosin Receptor Kinase Inhibitor Challenges and Efficacy in Real-World Pediatric Oncology.
Vince CSC; Brassesco MS; Mançano BM; Gregianin LJ; Carbone EK; do Amaral E Castro A; Dwan VSY; Menezes da Silva RZ; Mariano CS; da Mata JF; Silva MO; Caran EMM; Macedo CD; Alves da Costa G; Esteves TC; Silva LN; Ferman SE; Martins FD; Cristófani LM; Odone-Filho V; Silva MM; Reis RM; Pianovski MAD; Campregher PV; Kunii MS; de Sá Rodrigues KE; Carvalho Filho NP; Valera ET;
JCO Precis Oncol; 2024 May; 8():e2300713. PubMed ID: 38810175
[TBL] [Abstract][Full Text] [Related]
3. Healthcare decision-making for tumour-agnostic therapies in Europe: lessons learned.
Hogervorst MA; van Hattem CC; Sonke GS; Mantel-Teeuwisse AK; Goettsch WG; Bloem LT
Drug Discov Today; 2024 May; 29(7):104031. PubMed ID: 38796096
[TBL] [Abstract][Full Text] [Related]
4. Neonatal spindle-cell CD34-positive plaque-like tumour: a new entity characterised by NTRK gene fusion.
Drabent P; Kervarrec T; Tallet A; Fraitag S
Virchows Arch; 2024 May; ():. PubMed ID: 38789627
[No Abstract] [Full Text] [Related]
5. NTRK gene fusion testing and management in lung cancer.
Repetto M; Chiara Garassino M; Loong HH; Lopez-Rios F; Mok T; Peters S; Planchard D; Popat S; Rudzinski ER; Drilon A; Zhou C
Cancer Treat Rev; 2024 Jun; 127():102733. PubMed ID: 38733648
[TBL] [Abstract][Full Text] [Related]
6.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
7.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
8.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
